VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop

Óscar González-Moreno, Jon Lecanda, Jeffrey E. Green, +4

Experimental Cell Research

Epithelial-mesenchymal TransitionUrologyPerineural InvasionEpithelial-mesenchymal InteractionsAutocrine Loop +7

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer

Diego Serrano, Anne‐Marie Bleau, Ignacio Fernandez‐Garcia, +4

Molecular Cancer

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

Esther Redín, Irati Garmendia, Teresa Lozano, +16

Journal for ImmunoTherapy of Cancer

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

Clément Anfray, Francesco Mainini, Elisabeth Digifico, +15

Journal for ImmunoTherapy of Cancer

The Smc5/6 Core Complex Is a Structure-Specific DNA Binding and Compacting Machine

Diego Serrano, Gustavo Cordero, Ryo Kawamura, +7

Molecular Cell

ChromatinStructural BioinformaticsProtein FoldingNatural SciencesSmc5/6 Core Complex +10

Cell proliferation and morphometric changes in the rat kidney during postnatal development

María Márquez, I Docal Cabrera, Diego Serrano, +1

Anatomy and Embryology

Developmental BiologyRat KidneyMorphogenesisCell ProliferationNephrology +8

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144

Idoia G. Zubeldia, Anne‐Marie Bleau, Miriam Redrado, +6

Experimental Cell Research

Epithelial-mesenchymal TransitionMedicineLiver PhysiologyPathologyCancer Cell Biology +7

PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Francisco Expósito, Miriam Redrado, Maeva Houry, +23

Cancer Research

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

Roque Díaz, Paul Nguewa, Juan A. Díaz-González, +7

British Journal of Cancer

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

Celia Martín-Otal, Aritz Lasarte-Cía, Diego Serrano, +16

Journal for ImmunoTherapy of Cancer